Ionis Pharmaceuticals, Inc. (IONS): Price and Financial Metrics

Ionis Pharmaceuticals, Inc. (IONS): $42.71

0.23 (+0.54%)

POWR Rating

Component Grades








Add IONS to Watchlist
Sign Up

IONS Price/Volume Stats

Current price $42.71 52-week high $47.74
Prev. close $42.48 52-week low $32.69
Day low $42.10 Volume 704,500
Day high $43.07 Avg. volume 1,033,326
50-day MA $40.71 Dividend yield N/A
200-day MA $38.84 Market Cap 6.12B

IONS Stock Price Chart Interactive Chart >


  • Quality is the dimension where IONS ranks best; there it ranks ahead of 64.04% of US stocks.
  • The strongest trend for IONS is in Quality, which has been heading down over the past 179 days.
  • IONS's current lowest rank is in the Momentum metric (where it is better than 9.4% of US stocks).

IONS Stock Summary

  • Of note is the ratio of IONIS PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; merely 5.41% of US stocks have a lower such ratio.
  • Over the past twelve months, IONS has reported earnings growth of 1,316.9%, putting it ahead of 98.78% of US stocks in our set.
  • Revenue growth over the past 12 months for IONIS PHARMACEUTICALS INC comes in at -25.71%, a number that bests merely 10.21% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to IONIS PHARMACEUTICALS INC, a group of peers worth examining would be XBIT, RVMD, ABUS, IDYA, and ALPN.
  • IONS's SEC filings can be seen here. And to visit IONIS PHARMACEUTICALS INC's official web site, go to

IONS Valuation Summary

  • In comparison to the median Healthcare stock, IONS's price/earnings ratio is 173.03% lower, now standing at -19.9.
  • IONS's price/sales ratio has moved up 4.5 over the prior 243 months.

Below are key valuation metrics over time for IONS.

Stock Date P/S P/B P/E EV/EBIT
IONS 2023-09-18 9.8 14.4 -19.9 -30.0
IONS 2023-09-15 9.8 14.4 -19.9 -30.0
IONS 2023-09-14 9.9 14.6 -20.2 -30.4
IONS 2023-09-13 9.8 14.4 -20.0 -30.1
IONS 2023-09-12 9.9 14.6 -20.2 -30.4
IONS 2023-09-11 9.4 13.8 -19.1 -29.0

IONS Growth Metrics

    Its 2 year price growth rate is now at -29.96%.
  • Its year over year price growth rate is now at -0.78%.
  • Its 3 year cash and equivalents growth rate is now at 44.36%.
IONS's revenue has moved down $371,386,000 over the prior 34 months.

The table below shows IONS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 587.367 -274.37 -269.722
2022-09-30 875.483 129.512 7.321
2022-06-30 848.809 98.367 -28.153
2022-03-31 840.768 53.811 -3.893
2021-12-31 810.456 30.799 -28.597
2021-09-30 660.731 -74.911 -593.481

IONS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IONS has a Quality Grade of C, ranking ahead of 48.06% of graded US stocks.
  • IONS's asset turnover comes in at 0.277 -- ranking 161st of 682 Pharmaceutical Products stocks.
  • EDIT, MYMD, and VSTM are the stocks whose asset turnover ratios are most correlated with IONS.

The table below shows IONS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.277 0.982 -0.099
2021-06-30 0.269 0.983 -0.073
2021-03-31 0.262 0.983 -0.051
2020-12-31 0.250 0.984 -0.031
2020-09-30 0.298 0.990 0.050
2020-06-30 0.306 0.992 0.063

IONS Price Target

For more insight on analysts targets of IONS, see our IONS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $55.82 Average Broker Recommendation 1.82 (Hold)

Ionis Pharmaceuticals, Inc. (IONS) Company Bio

Ionis Pharmaceuticals, Inc., a RNA-targeted drug discovery and development company, focuses on developing drugs for patients with severe and rare diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.

IONS Latest News Stream

Event/Time News Detail
Loading, please wait...

IONS Latest Social Stream

Loading social stream, please wait...

View Full IONS Social Stream

Latest IONS News From Around the Web

Below are the latest news stories about IONIS PHARMACEUTICALS INC that investors may wish to consider to help them evaluate IONS as an investment opportunity.

The 7 Most Hated Stocks by Institutional Traders

Discover the surprising stocks institutional traders are selling, and find out what their moves could mean for your portfolio's future.

Josh Enomoto on InvestorPlace | September 20, 2023

Ionis to host investor and analyst day event

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host an investor and analyst day on Wednesday, October 4. The event will take place at the Westin New York Grand Central from 8:00 a.m. to 3:00 p.m. Eastern Time and will also be webcast. The agenda will include presentations by members of the Ionis management team and the following notable key opinion leaders:

Yahoo | September 12, 2023

Why Is Ionis Pharmaceuticals (IONS) Up 1.4% Since Last Earnings Report?

Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 8, 2023

Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

Yahoo | August 30, 2023

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript August 9, 2023 Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.6, expectations were $-0.94. Operator: Good morning, and welcome to Ionis’ Second Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn […]

Yahoo | August 11, 2023

Read More 'IONS' Stories Here

IONS Price Returns

1-mo 5.93%
3-mo 9.23%
6-mo 24.56%
1-year -1.20%
3-year -12.19%
5-year -17.10%
YTD 13.08%
2022 24.12%
2021 -46.18%
2020 -6.41%
2019 11.75%
2018 7.48%

Continue Researching IONS

Want to see what other sources are saying about Ionis Pharmaceuticals Inc's financials and stock price? Try the links below:

Ionis Pharmaceuticals Inc (IONS) Stock Price | Nasdaq
Ionis Pharmaceuticals Inc (IONS) Stock Quote, History and News - Yahoo Finance
Ionis Pharmaceuticals Inc (IONS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!